Patents by Inventor Jessica Powell

Jessica Powell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT
    Publication number: 20240002549
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 4, 2024
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, JR., Andrew C. Yang
  • METHODS OF IMPROVING RETINA-ASSOCIATED DISEASE OUTCOME USING CCR3-INHIBITORS
    Publication number: 20230312697
    Abstract: The disclosure provides a method of reducing the frequency of administration of an anti-VEGF agent to a subject diagnosed with wet age-related macular degeneration. The method comprises administering a CCR3 inhibitory agent to the subject; administering the anti-VEGF agent to the subject after the administering of the CCR3 inhibitory agent; and administering additional subsequent doses of the anti-VEGF agent to the subject at a frequency less than the recommended frequency. The disclosure further provides a method of treating a subject suffering from a retina-associated disease, the method comprising administering an anti-VEGF agent to a subject suffering from a retina-associated disease and previously treated with a CCR3 inhibitory agent, wherein the anti-VEGF agent is administered at a frequency less than the recommended frequency for the anti-VEGF agent.
    Type: Application
    Filed: June 9, 2021
    Publication date: October 5, 2023
    Inventors: Bartosz Sikorski, Elizabeth W. Jeffords, Erin McCaskill Newman, Jessica A. Powell, Esther Rawner
  • Reactive polysaccharide-based hemostatic agent
    Patent number: 11739166
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: August 29, 2023
    Assignee: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, Jr., Andrew C. Yang
  • FLOWABLE HEMOSTATIC SUSPENSION
    Publication number: 20220001075
    Abstract: Compositions and methods related to flowable hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Frederick H. Strickler, JR., Andrew C. Yang, Rajendra R. Bhat, Jessica Powell, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant
  • REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT
    Publication number: 20220002444
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, JR., Andrew C. Yang